These 5 stocks each have strong share price momentum backed up by strong recent profit growth.

Magellan Global Fund (ASX: MGF) trades at a 22.5% discount to net asset value (NAV). Is this too cheap?

Whispir (ASX: WSP) shareholders should consider if Whispir will raise capital again. When will there be another Whispir capital raising?

In Raymond Jang’s last piece for A Rich Life, he reflects on key investing lessons, his filtering process, and the road ahead as an investor.

By acquiring PaulCamper, Camplify (ASX: CHL) is building much-needed scale in the European market.

In FY 2022, the Altium results saw strong profit growth. But does Altium have a sustainable competitive advantage?

Resources for small cap investment research will naturally have a bias. Improve your investing by considering the biases of your research.

The Supply Network results (ASX: SNL) were great, in FY 2022, but competitor Maxiparts (ASX: MXI) is ready to pounce.

When fear reigns it is hard to force yourself to buy growth stocks, but these three have all stood the test of time and showed their quality in good times and bad.

Catapult International results in FY 2022 were weak, and now Catapult is laying off employees. Should Catapult shareholders worry?

The Atomos results for FY 2022 were not a pretty picture, even before the auditor demanded revenue be revised lower.

Human instincts make investors too conservative at the time of maximum opportunity, so I use pre-identified signs to overcome my hesitance.

The Cogstate share price is up today because of favourable clinical trial results from its partner Eisai. Why does it matter?

Netwealth market share keeps growing and I Netwealth competition faces challenges. However, keeping ahead of competition comes at a cost.

Before even thinking of buying shares in XPON Technologies, you need to understand the XPON business model.

When fear reigns it is hard to force yourself to buy growth stocks, but these are the half dozen I have most faith in (at the right price).

Mader Group has experienced stellar growth since listing in late 2019. Growth in the USA could take it to the next level.

The company initially planned to raise just $7.5m at $4.50 per share, but has increased the total due to high demand from institutions.

Baby Bunting competitors have come and gone since listing in October 2015. How has it become the leading baby retailer on the ASX?

PWR Holdings results, Objective
results, Alcidion results, Lovisa results and Laserbond results were all strong in FY 2022.